Founded in 1994 – TRINA BIOREACTIVES has a track record of achievement, supplying to over 40 countries worldwide, driven by Quality and our customer needs. The constant challenge to improve our products through the compliance, efficiency, and cost effectiveness of sustainable supply chains.

Achievements

Founded in Switzerland through Heidi Flückiger: 1994
Achieved first large contracts for IVD: 1996
Launch of Asian Divison and offices in Japan: 1998
Decison to become a Leader in supplying IVD Manufacturers: 2005
Generation Change - Adrian Jencik takes on CEO: 2008
Martin Renggli joins as COO and Global Sales Manager: 2012
Extending the Quality Control and Production: 2014
Becoming key player in Disease State Plasma materials: 2016

Market Overview

TRINA has proven to be a reliable industry partner for the customized procurement of biochemical components to the diagnostic manufacturing. The IVD Market is healthy and growing global subsection of the Medical Market. Over 70% of all medical decisions are made based on diagnostic data. New technologies and a population that grows older globally are the key drivers for innovation and horizontal expansion.

Immunoassay Cardiac Tumor - Brochure